Perrigo Company plc (PRGO) vs Xeris Biopharma Holdings, Inc. (XERS)
- Perrigo Company plc PRGO 16.63 +0.91%
- Xeris Biopharma Holdings, Inc. XERS 10.31 +2.38%
Perrigo Company plc and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc is the larger, with a market value of $2.3B against $1.8B — 1.2× the size. Xeris Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 36.3% against −4.19%. Xeris Biopharma Holdings, Inc. has the higher net margin (−5.12% vs −41.9%) and the higher return on invested capital (18.9% vs −18.1%). Across the 18 metrics below, Xeris Biopharma Holdings, Inc. leads on 12 and Perrigo Company plc on 6.
Valuation
Profitability
| Metric | PRGO | XERS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 33.26% | 86.58% | 53.94% |
| Operating margin | (37.71%) | 10.91% | 0.00% |
| Net margin | (41.85%) | (5.12%) | 0.00% |
| Free cash flow margin | 2.88% | 16.60% | 0.00% |
| Return on equity | (49.65%) | 118.22% | (0.40%) |
| Return on assets | (19.60%) | (4.60%) | (3.32%) |
| Return on invested capital | (18.06%) | 18.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack